BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 23959870)

  • 21. Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice.
    Bayer TA; Schäfer S; Simons A; Kemmling A; Kamer T; Tepest R; Eckert A; Schüssel K; Eikenberg O; Sturchler-Pierrat C; Abramowski D; Staufenbiel M; Multhaup G
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14187-92. PubMed ID: 14617773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse.
    Shang J; Yamashita T; Tian F; Li X; Liu X; Shi X; Nakano Y; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
    Brain Res; 2019 Nov; 1723():146379. PubMed ID: 31415766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E isoform-specific effects on lipoprotein receptor processing.
    Bachmeier C; Shackleton B; Ojo J; Paris D; Mullan M; Crawford F
    Neuromolecular Med; 2014 Dec; 16(4):686-96. PubMed ID: 25015123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.
    Deane R; Sagare A; Hamm K; Parisi M; Lane S; Finn MB; Holtzman DM; Zlokovic BV
    J Clin Invest; 2008 Dec; 118(12):4002-13. PubMed ID: 19033669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LRP1 Has a Predominant Role in Production over Clearance of Aβ in a Mouse Model of Alzheimer's Disease.
    Van Gool B; Storck SE; Reekmans SM; Lechat B; Gordts PLSM; Pradier L; Pietrzik CU; Roebroek AJM
    Mol Neurobiol; 2019 Oct; 56(10):7234-7245. PubMed ID: 31004319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells.
    Lee J; Lee H; Lee H; Shin M; Shin MG; Seo J; Lee EJ; Park SA; Park S
    Nat Commun; 2023 Dec; 14(1):8463. PubMed ID: 38123547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier.
    Bachmeier C; Beaulieu-Abdelahad D; Mullan M; Paris D
    Mol Cell Neurosci; 2013 Sep; 56():255-62. PubMed ID: 23831388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease.
    Rolyan H; Feike AC; Upadhaya AR; Waha A; Van Dooren T; Haass C; Birkenmeier G; Pietrzik CU; Van Leuven F; Thal DR
    J Neural Transm (Vienna); 2011 May; 118(5):699-712. PubMed ID: 21210284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier.
    Pflanzner T; Janko MC; André-Dohmen B; Reuss S; Weggen S; Roebroek AJ; Kuhlmann CR; Pietrzik CU
    Neurobiol Aging; 2011 Dec; 32(12):2323.e1-11. PubMed ID: 20630619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Copper complexing decreases the ability of amyloid beta peptide to cross the BBB and enter brain parenchyma.
    Mare S; Penugonda S; Robinson SM; Dohgu S; Banks WA; Ercal N
    Peptides; 2007 Jul; 28(7):1424-32. PubMed ID: 17580097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport.
    Guo YX; He LY; Zhang M; Wang F; Liu F; Peng WX
    Neuroscience; 2016 May; 322():28-38. PubMed ID: 26820600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease.
    Jaeger LB; Dohgu S; Sultana R; Lynch JL; Owen JB; Erickson MA; Shah GN; Price TO; Fleegal-Demotta MA; Butterfield DA; Banks WA
    Brain Behav Immun; 2009 May; 23(4):507-17. PubMed ID: 19486646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Copper-Induced Upregulation of MicroRNAs Directs the Suppression of Endothelial LRP1 in Alzheimer's Disease Model.
    Hsu HW; Rodriguez-Ortiz CJ; Lim SL; Zumkehr J; Kilian JG; Vidal J; Kitazawa M
    Toxicol Sci; 2019 Jul; 170(1):144-156. PubMed ID: 30923833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of copper and the copper-related protein CUTA in mediating APP processing and Aβ generation.
    Hou P; Liu G; Zhao Y; Shi Z; Zheng Q; Bu G; Xu H; Zhang YW
    Neurobiol Aging; 2015 Mar; 36(3):1310-5. PubMed ID: 25557959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease.
    Hartz AM; Miller DS; Bauer B
    Mol Pharmacol; 2010 May; 77(5):715-23. PubMed ID: 20101004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High affinity of β-amyloid proteins to cerebral capillaries: implications in chronic lead exposure-induced neurotoxicity in rats.
    Liu LL; Shen X; Gu H; Zhao G; Du Y; Zheng W
    Fluids Barriers CNS; 2023 May; 20(1):32. PubMed ID: 37122007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-β in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice.
    Gali CC; Fanaee-Danesh E; Zandl-Lang M; Albrecher NM; Tam-Amersdorfer C; Stracke A; Sachdev V; Reichmann F; Sun Y; Avdili A; Reiter M; Kratky D; Holzer P; Lass A; Kandimalla KK; Panzenboeck U
    Mol Cell Neurosci; 2019 Sep; 99():103390. PubMed ID: 31276749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased beta-amyloid levels in the choroid plexus following lead exposure and the involvement of low-density lipoprotein receptor protein-1.
    Behl M; Zhang Y; Monnot AD; Jiang W; Zheng W
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):245-54. PubMed ID: 19501112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.